The BISKUIT project (biosensor for a cost-efficient and rapid determination of immune status), funded by the state of Baden-Württemberg, has been successfully completed by BioCopy. As part of the project, measurements were performed over the last eight months, to determine the immunity against SARS-COV2 and its variants. For this purpose, serum samples from COVID-19 recovered subjects and subjects immunized with different vaccines were analyzed for approximately 100 mutants of SARS-COV2. Only 50µl of serum from the subjects was needed for the analysis. Through the measurements, the acute protection of the subjects against the different SARS-COV2 variants could be determined.
Read the project report (German only)